X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-01-27 | OPNT | Crystal Roger | CEO, 10% | S - Sale | $20.26 | -1,358 | 75,339 | -2% | -$27,513 | ||||||
2023-01-27 | OPNT | Ellison Mark Jason Heath | Chief Development Officer | S - Sale | $20.26 | -610 | 18,751 | -3% | -$12,359 | ||||||
2023-01-27 | OPNT | Gorman Brian | General Counsel | S - Sale | $20.26 | -444 | 31,990 | -1% | -$8,995 | ||||||
2023-01-27 | OPNT | Skolnick Phil | Chief Scientific Officer | S - Sale | $20.26 | -480 | 21,548 | -2% | -$9,725 | ||||||
2023-01-27 | OPNT | O'Toole David D | CFO | S - Sale | $20.26 | -541 | 34,248 | -2% | -$10,961 | ||||||
2023-01-09 | OPNT | O'Toole David D | CFO | S - Sale | $20.20 | -415 | 34,789 | -1% | -$8,383 | ||||||
2023-01-09 | OPNT | Ellison Mark Jason Heath | Chief Development Officer | S - Sale | $20.20 | -469 | 19,361 | -2% | -$9,474 | ||||||
2023-01-09 | OPNT | Skolnick Phil | Chief Scientific Officer | S - Sale | $20.20 | -369 | 22,028 | -2% | -$7,454 | ||||||
2023-01-09 | OPNT | Crystal Roger | CEO, 10% | S - Sale | $20.20 | -1,183 | 76,697 | -2% | -$23,897 | ||||||
2023-01-05 | OPNT | Ellison Mark Jason Heath | Chief Development Officer | S - Sale | $20.20 | -1,806 | 19,830 | -8% | -$36,481 | ||||||
2023-01-05 | OPNT | O'Toole David D | CFO | S - Sale | $20.20 | -1,600 | 35,204 | -4% | -$32,320 | ||||||
2023-01-05 | OPNT | Gorman Brian | General Counsel | S - Sale | $20.20 | -1,313 | 32,434 | -4% | -$26,523 | ||||||
2023-01-05 | OPNT | Skolnick Phil | Chief Scientific Officer | S - Sale | $20.20 | -1,421 | 22,397 | -6% | -$28,704 | ||||||
2023-01-05 | OPNT | Crystal Roger | CEO, 10% | S - Sale | $20.20 | -5,029 | 77,880 | -6% | -$101,586 | ||||||
2022-07-20 | OPNT | Ruth Matthew R. | Chief Commercial Officer | S - Sale | $10.62 | -1,084 | 29,916 | -3% | -$11,512 | ||||||
2022-07-14 | OPNT | O'Toole David D | CFO | S - Sale | $11.10 | -779 | 36,804 | -2% | -$8,647 | ||||||
2022-07-14 | OPNT | Skolnick Phil | Chief Scientific Officer | S - Sale | $11.85 | -627 | 23,818 | -3% | -$7,430 | ||||||
2022-07-14 | OPNT | Gorman Brian | General Counsel | S - Sale | $11.16 | -691 | 33,747 | -2% | -$7,712 | ||||||
2022-07-14 | OPNT | Crystal Roger | CEO, 10% | S - Sale | $11.11 | -2,246 | 82,909 | -3% | -$24,953 | ||||||
| M | 2022-06-13 | OPNT | Sinclair Michael | Dir, 10% | S - Sale | $10.96 | -13,616 | 19,220 | -41% | -$149,188 | |||||
| M | 2022-06-10 | OPNT | Collard Craig A | Dir | P - Purchase | $11.10 | +5,700 | 53,822 | +12% | +$63,266 | |||||
2022-06-09 | OPNT | Sinclair Michael | Dir, 10% | S - Sale | $12.25 | -7,896 | 32,836 | -19% | -$96,726 | ||||||
| M | 2022-06-06 | OPNT | Sinclair Michael | Dir, 10% | S - Sale | $12.93 | -8,488 | 40,732 | -17% | -$109,771 | |||||
| M | 2022-06-02 | OPNT | Sinclair Michael | Dir, 10% | S - Sale | $13.73 | -20,000 | 49,220 | -29% | -$274,623 | |||||
2022-06-02 | OPNT | Gorman Brian | General Counsel | S - Sale | $13.52 | -1,148 | 32,438 | -3% | -$15,521 | ||||||
2022-05-16 | OPNT | Silver Gabrielle Alison | Dir | P - Purchase | $13.29 | +2,500 | 21,343 | +13% | +$33,220 | ||||||
2022-05-16 | OPNT | Collard Craig A | Dir | P - Purchase | $13.54 | +27,150 | 48,122 | +129% | +$367,611 | ||||||
2022-05-13 | OPNT | Collard Craig A | Dir | P - Purchase | $10.49 | +3,689 | 20,972 | +21% | +$38,698 | ||||||
2022-05-13 | OPNT | Macdougall Ann L. | Dir | P - Purchase | $10.93 | +3,000 | 26,179 | +13% | +$32,778 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |